Myasthenia Gravis: Mechanisms and Management

Publisher Website
Google Scholar
Abstract
Myasthenia gravis is an autoimmune disease of known cause: an antibody to a specific molecule of defined structure. As long as the abnormality leading to the antibody response remains elusive, however, so will ideal treatment. In the meantime, most patients given proper management can lead normal or near-normal lives; prognosis is surprisingly good, and mortality should approach zero.